What they found
Emerging evidence shows that microplastics and nanoplastics (MNPs) accumulate in cardiovascular tissues and induce cellular injury, positioning them as an emerging cardiovascular risk factor. These particles contribute to atherosclerotic development, plaque destabilization, and cardiac remodeling.
What they studied
This review synthesized experimental, translational, and early clinical studies to understand how microplastics and nanoplastics (MNPs) contribute to cardiovascular disease. It examined mechanisms like oxidative stress, endothelial dysfunction, and immune activation.
Takeaways
The abstract focuses on the scientific findings regarding microplastics and nanoplastics as cardiovascular toxins; it does not provide personal how-to steps for individuals.
About this paper
This paper is a review that synthesizes existing experimental, translational, and early clinical studies. It highlights major knowledge gaps, including the absence of standardized exposure biomarkers, dose-response quantification, and longitudinal clinical cohorts.